TRAPEZE_1B | R Documentation |
Kaplan-Meier digitized data from TRAPEZE, figure 1B (PMID 26794729). A reported sample size of 757 for a primary endpoint of cPFS,cost-effectiveness in prostate cancer.
TRAPEZE_1B
A data frame of 757 observations and 3 variables:
time | event time (in months) | |
event | PFS event indicator (0 : no event, 1 : event) |
|
arm | treatment arms (no_sr89, sr89) | |
James ND, Pirrie SJ, Pope AM, et al. Clinical Outcomes and Survival Following Treatment of Metastatic Castrate-Refractory Prostate Cancer With Docetaxel Alone or With Strontium-89, Zoledronic Acid, or Both: The TRAPEZE Randomized Clinical Trial. JAMA Oncol 2016; 2: 493–9.
summary(TRAPEZE_1B)
kmplot(TRAPEZE_1B)
Add the following code to your website.
For more information on customizing the embed code, read Embedding Snippets.